As the first federal opioid trial neared, the pharma industry scrambled to negotiate settlements. The case brought by two Ohio counties was set to be a bellwether for the remaining federal lawsuits. Over two months, nearly every major drug company reached a settlement to avoid the Ohio trial while negotiating larger settlements to resolve 2,500 other federal cases. Read on to see how these negotiations played out.
Thank you for accessing MM+M.
Create your free account or log in to continue reading this premium content.